Clinitech Laboratory IPO

NiftyTrader • July 21, 2024

Post Views: 1,055

Clinitech Laboratory IPO opens on July 25, 2024, and closes on July 29, 2024. The allotment for the Clinitech Laboratory IPO is anticipated to be completed on Tuesday, July 30, 2024. The IPO will be listed on the BSE and SME, with a tentative date of Wednesday, August 1,2024.

The price band for the Clinitech Laboratory IPO is set at Rs 96 per share. The IPO is a book-built issue of Rs 5.78 crores, entirely a fresh issue of 6.02 Lakhs shares.

Clinitech Laboratory IPO Details

IPO Date	July 25, 2024 to July 29, 2024
Listing Date	[.]
Face Value	₹10 per share
Price	₹96 per share
Lot Size	1200 Shares
Total Issue Size	602,400 shares (aggregating up to ₹5.78 Cr)
Fresh Issue	602,400 shares (aggregating up to ₹5.78 Cr)
Issue Type	Fixed Price Issue IPO
Listing At	BSE SME
Shareholding pre-issue	1,680,000
Shareholding post-issue	2,282,400
Market Maker portion	31,200 shares

Clinitech Laboratory IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	1	1200	₹115,200
Retail (Max)	1	1200	₹115,200
HNI (Min)	2	2400	₹230,400

Clinitech Laboratory IPO Objectives

The objectives of the Issue are:

Expansion of Diagnostic Centres; and
General Corporate Purpose.

About Clinitech Laboratory Limited

Founded in 1990, Clinitech Laboratory Limited operates as a diagnostic and healthcare services provider with a network of eight diagnostic centers located in and around Thane and Navi Mumbai. The company offers over 150 different tests and conducts more than three lakh tests annually. Clinitech Laboratory’s facilities are equipped with modern technology and high-quality equipment, ensuring accurate and reliable results. The company’s commitment to quality is reflected in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation.

The medical testing facilities at Clinitech Laboratory’s Airoli, Navi Mumbai center have been accredited by NABL as per ISO 15189:2012. This accreditation underscores the laboratory’s adherence to international standards in medical testing, ensuring the highest levels of accuracy and reliability in their diagnostic services. Clinitech Laboratory continues to uphold its reputation for excellence in the healthcare industry, providing essential diagnostic services to the community.

Clinitech Laboratory Limited Financial Information

Clinitech Laboratory Limited’s revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	560.79	603.33	368.74	273.32
Revenue	643.92	636.34	645.70	459.63
Profit After Tax	37.12	61.31	51.26	40.24
Net Worth	354.80	238.08	184.81	139.03
Reserves and Surplus	186.80	88.08	34.81	72.37
Total Borrowing	86.31	102.91	88.61	53.67

Clinitech Laboratory IPO Reservation

Investor Category	Shares Offered
Retail Shares Offered	50% of the Net Issue
Other Shares Offered	50% of the Net Issue

Clinitech Laboratory IPO Timeline

Clinitech Laboratory IPO opens on July 25, 2024, and closes on July 29, 2024.

IPO Open Date	Thursday, July 25, 2024
IPO Close Date	Monday, July 29, 2024
Basis of Allotment	Tuesday, July 30, 2024
Initiation of Refunds	Wednesday, July 31, 2024
A credit of Shares to Demat	Wednesday, July 31, 2024
Listing Date	Thursday, August 1, 2024
Cut-off time for UPI mandate confirmation	5 PM on July 29, 2024

Conclusion

Clinitech Laboratory Limited, a prominent diagnostic and healthcare services provider established in 1990, is launching its IPO from July 25 to July 29, 2024, with shares priced at Rs 96 each. The IPO, a fixed price issue, aims to raise Rs 5.78 crores through a fresh issue of 602,400 shares. The proceeds will fund the expansion of diagnostic centers and general corporate purposes. Clinitech, accredited by NABL, operates eight centers in Thane and Navi Mumbai, offering over 150 tests annually. Despite a revenue increase, their profit after tax saw a significant drop in the latest fiscal year. The shares will be listed on the BSE SME on August 1, 2024.